$80.2 Million is the total value of HealthInvest Partners AB's 11 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 90.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANTM | New | ANTHEM INC | $10,385,000 | – | 55,200 | +100.0% | 12.95% | – |
| MCK | Buy | MCKESSON CORP | $10,382,000 | +37.3% | 63,100 | +23.7% | 12.95% | +11.7% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $10,370,000 | -7.0% | 109,700 | -12.9% | 12.93% | -24.4% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $7,102,000 | -7.8% | 70,212 | -18.0% | 8.86% | -25.0% |
| LH | New | LABORATORY CORP AMER HLDGS | $7,060,000 | – | 45,800 | +100.0% | 8.80% | – |
| GILD | Sell | GILEAD SCIENCES INC | $6,908,000 | -13.1% | 97,600 | -16.6% | 8.61% | -29.3% |
| PFE | New | PFIZER INC | $6,879,000 | – | 204,800 | +100.0% | 8.58% | – |
| LGND | New | LIGAND PHARMACEUTICALS INC | $6,823,000 | – | 56,200 | +100.0% | 8.51% | – |
| BIIB | New | BIOGEN INC | $6,784,000 | – | 25,000 | +100.0% | 8.46% | – |
| ANIK | Sell | ANIKA THERAPEUTICS INC | $6,168,000 | -21.8% | 125,000 | -31.2% | 7.69% | -36.4% |
| ICCC | Buy | IMMUCELL CORP | $1,335,000 | +43.4% | 182,133 | +8.2% | 1.66% | +16.6% |
| ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -497,807 | -100.0% | -3.21% | – |
| GNCIQ | Exit | GNC HLDGS INC | $0 | – | -422,955 | -100.0% | -4.77% | – |
| OSIR | Exit | OSIRIS THERAPEUTICS INC NEW | $0 | – | -1,140,222 | -100.0% | -8.39% | – |
| AET | Exit | AETNA INC NEW | $0 | – | -89,000 | -100.0% | -17.41% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-07
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
| GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
| CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
| IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
| MCKESSON CORP | 14 | Q3 2022 | 14.6% |
| ANTHEM INC | 12 | Q4 2017 | 14.3% |
| TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
| LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
| SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
| ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
| THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
| BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
| ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
| SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
| CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
| INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
| AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
| OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
| ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-25 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-08 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-11-08 |
| 13F-HR | 2021-08-10 |
| 13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.